5

DRUG2 trials

Sponsors

Universitair Medisch Centrum Groningen, Universitair Medisch Centrum Groningen, Rheinische Friedrich-Wilhelms-Universitaet Bonn

Conditions

COVID-19Herpes ZosterOverweight or ObesityPolycystic Ovary Syndrome (PCOS)impaired immunitykidney transplantation

Phase 3

Prospective Randomized trial of Everolimus replacing MMF/MP Acid by the RECOVAC consortium to increase VACcine response in kidney transplant patients

CompletedCTIS2023-503894-39-00

Universitair Medisch Centrum Groningen, Universitair Medisch Centrum GroningenCOVID-19, Herpes Zoster, impaired immunity +1

Start: 2023-08-22End: 2024-02-27Target: 110Updated: 2023-10-10

Phase 4

A Clinical Trial of Tirzepatide (LY3298176) in Subjects With Overweight or Obesity and PCOS-related Ovarian Dysfunction (PERIODS)

RecruitingCTIS2024-515982-32-00

Rheinische Friedrich-Wilhelms-Universitaet BonnOverweight or Obesity, Polycystic Ovary Syndrome (PCOS)

Start: 2025-12-09Target: 198Updated: 2025-10-06